APPLICATION
ANDA075423
TYPE
ANDA
ORIGINAL APPROVAL
2001-04-27
LATEST ACTION
2012-06-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CLONAZEPAMDiscontinued
CLONAZEPAM 0.5MG · TABLET · ORAL
CLONAZEPAMDiscontinued
CLONAZEPAM 1MG · TABLET · ORAL
CLONAZEPAMDiscontinued
CLONAZEPAM 2MG · TABLET · ORAL
Approval history
2012-06-20Labeling · Supplement 19 · standardAP
2011-04-08Labeling · Supplement 14AP
2011-04-08REMS · Supplement 15AP
2009-11-02Labeling · Supplement 13AP
2005-09-15Labeling · Supplement 6AP
2003-02-20Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.